Follica lands $5.5M in first round
Boston-based Follica has landed $5.5 million in its first round of financing. Interwest Partners led the round and existing investors PureTech Ventures also contributed. Follica is developing a therapy for androgenetic alopecia and other hair follicle disorders. The company will use to funding to complete a clinical proof of concept study.
"There is a great need for novel therapies; androgenetic alopecia begins as early as the teenage years or twenties, and affects about half the men and women in the United States by the age of 50," noted Follica co-founder Vera Price.
- see this release for more
Be the first to comment
More stories about Boston
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets

